Are you Dr. Becherer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2304 Wesvill Ct
Suite 240
Raleigh, NC 27607Phone+1 919-571-1567Fax+1 919-782-1472
Summary
- Dr. Paul Becherer, MD is an infectious disease specialist in Raleigh, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with UNC REX Health Care, Duke Raleigh Hospital, and WakeMed Raleigh Campus.
Education & Training
- University of North Carolina HospitalsFellowship, Infectious Disease, 1987 - 1990
- University of North Carolina HospitalsResidency, Internal Medicine, 1983 - 1987
- University of Illinois College of MedicineClass of 1983
Certifications & Licensure
- NC State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 8 citationsThe use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients.R. Marty Cooney, Nisha Manickam, Paul Becherer, Laura S. Harmon, Liza Gregg
British Journal of Nursing. 2020-01-23 - 68 citationsEffectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: ...Deverick J. Anderson, Rebekah W. Moehring, David J. Weber, Sarah S. Lewis, Luke F. Chen
The Lancet. Infectious Diseases. 2018-06-04 - 210 citationsEnhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal ...Deverick J. Anderson, Luke F. Chen, David J. Weber, Rebekah W. Moehring, Sarah S. Lewis
Lancet. 2017-02-25